Ticker
BIAFCompany Name
BIOAFFINITY TECHNOLOGIES INCSector
HealthcareIndustry
Diagnostics & ResearchExchange
NASDAQDate | Cash and Equivalents | Total Debt | Enterprise Value | Market Capitalization |
---|---|---|---|---|
6/30/2025 | $ 802.84K | $ 670K | $ 7.13M | $ 7.27M |
3/31/2025 | $ 444.71K | $ 1.33M | $ 6.49M | $ 5.6M |
12/31/2024 | $ 1.11M | $ 1.5M | $ 5.14M | $ 4.75M |
9/30/2024 | $ 756.58K | $ 1.72M | $ 21.69M | $ 20.73M |
6/30/2024 | $ 801.31K | $ 1.38M | $ 24.52M | $ 23.94M |
3/31/2024 | $ 2.45M | $ 1.49M | $ 20.96M | $ 21.92M |
12/31/2023 | $ 2.82M | $ 1.58M | $ 22.82M | $ 24.07M |
9/30/2023 | $ 4.51M | $ 1.69M | $ 10.87M | $ 13.69M |
6/30/2023 | $ 8.28M | $ 42.33K | $ 8.01M | $ 16.25M |
3/31/2023 | $ 9.77M | $ 168.43K | $ 5.65M | $ 15.25M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Market Cap + Debt - CashnEq
(=) EV
EV for BIOAFFINITY TECHNOLOGIES INC is calculated as follows: Market Cap [ $ 0 ] + Debt [ $ 11.36M ] - CashnEq [ $ 1.36M ]
(=) EV [ $ 0 ]
Minimum
Dec 31, 2022
Maximum
Jun 30, 2024
Average
Median
filtered constituents | 3.32K |
---|---|
min | $ -1.69B |
max | $ 6.88B |
average | $ 1.25B |
median | $ 439.6M |
std | $ 1.67B |